Effect of dexamethasone and ketorolac on edema and ecchymosis after rhinoplasty

Comparison of the effect of Dexamethasone and Ketorolac, separately on post rhinoplasty edema and ecchymosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220803055606N1

Enrollment

Registered

2022-09-20

Start date

2022-07-11

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty.

Interventions

Intervention 1: In intervention group 1, patients will receive intravenous dexamethasone (8 mg, IRANHORMONE), one dose before and three doses every 8 hours after surgery. Intervention 2: Patients in i

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 18-45 years Patients who are candidate for rhinoplasty

Exclusion criteria

Exclusion criteria: History of previous nose surgery Need for septoplasty Need osteotomy Heart failure Drug abuse History of hypersensitivity to non-steroidal anti-inflammatory drugs History of ulcerative gastrointestinal disease Diabetes Asthma Pulmonary failure Renal failure Nasal fracture

Design outcomes

Primary

Measure	Time frame
Severity of peri-ocular edema based on standard 4-grade scoring tool. Timepoint: 7 days after the operation. Method of measurement: standard 4-grade scoring tool.;Severity of peri-ocular ecchymosis based on standard 4-grade scoring tool. Timepoint: 7 days after the operation. Method of measurement: standard 4-grade scoring tool.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bijan Nagibzadeh

Shahid Beheshti University of Medical Sciences

info@drnaghibzadeh.com+98 21 5541 9005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026